Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35‐day cold‐storage regardless of leukoreduction timing-Reference-Cited by-同舟云学术

Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35‐day cold‐storage regardless of leukoreduction timing

Published:2022-06-24 Issue:S1 Volume:62 Page:
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Schubert Peter¹²³^ORCID,Culibrk Brankica¹²,Bhakta Varsha⁴,Closas Tatiana¹,Sheffield William P.⁴⁵^ORCID,Devine Dana V.¹²³^ORCID,McTaggart Ken⁶

Affiliation:

1. Medical Affairs and Innovation Canadian Blood Services Vancouver Canada

2. Center for Blood Research Vancouver Canada

3. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver Canada

4. Medical Affairs and Innovation Canadian Blood Services Hamilton Canada

5. Department Pathology and Molecular Medicine McMaster University Hamilton Canada

6. Medical Affairs and Innovation Canadian Blood Services Ottawa Canada

Funder

Health Canada

Terumo BCT

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16977

Reference22 articles.

1. Whole blood versus component therapy for haemostatic resuscitation of major bleeding: a protocol for a systematic review and meta-analysis

2. The difference in potential harms between whole blood and component blood transfusion in major bleeding: a rapid systematic review and meta‐analysis of RCTs;Geneen LJ;Transfus Med Rev,2022

3. Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta‐analysis

4. The use of whole blood in traumatic bleeding: a systematic review

5. Re‐introducing whole blood for transfusion: considerations for blood providers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expired blood transfusion and mortality outcomes in combat trauma patients;Transfusion;2024-07-05

2. Intentional transfusion of expired blood products;Transfusion;2024-02-21

3. Delayed Leukoreduction of whole blood with a platelet‐sparing filter to increase low‐titer group O whole blood production in the United States;Transfusion;2023-04-20